FDA Updates Guidance for Generic Drug Development, Withdraws Obsolete Documents

Summary

The FDA is updating its guidance for generic drug manufacturers on the development of generic drug products, while also withdrawing a list of outdated documents that have been replaced by new guidelines or agency directives.